Improving the guidelines for Informed Consent

i-CONSENT, funded by the European Union H2020 programme, aims to improve the information that patients receive from clinical studies. Within the project, a series of guidelines to improve Informed Consent process will be created, including vulnerable populations, under a gender perspective and relying on ICT tools.

i-CONSENT present at the European Research Night 2019

i-CONSENT will participate in this year's edition to introduce the subject of informed consent in clinical studies The LUMSA University participates for the fourth consecutive year in the European Researchers' Night to bring researchers and their work close to...

read more

When assent becomes as important as consent

Minor’s Assent in Medical Research: Differences between the Scientific Literature and the Legal Requirements Informed consent in medical studies with minors is a subject of great importance. There is still a debate about the requirements to consider this assent valid...

read more
Visit our Twitter and get the latest content!
@ICONSENTEU

@GVAfisabio @JardiBotanicUV El #AIV estará presente el Jueves 17 de octubre en el X Congreso Nacional de Biobancos (@Red_Biobancos) llevando nuestro proyecto @ICONSENTEU. Nuestro compañero @jaimefonsm hablará sobre participación y retorno de la información. ¡No te lo puedes perder!

Load More...

i-CONSENT in Numbers

From 2017 to 2020

Partners

Million EU Funding

Countries

Years Duration

Multimedia

 i-CONSENT falls under the ‘Science with and for Society’ (SWAFS) programme, which means that finding ways of connecting science to society is one of its main goals. Well aware of this, i-CONSENT is committed to citizens’ health literacy not only as a solution to make science more attractive to them but also as a way of empowering them leading to a true autonomy and self-government when deciding to participate in health-related studies. This section will offer visitors and stakeholders information on the project, in particular, and  knowledge on clinical trials, research and ethics, in general.